Cue Biopharma, Inc. (CUE)

We are an innovative biopharmaceutical company developing a novel and
proprietary class of biologic drugs for the selective modulation of the human
immune system to treat a broad range of cancers and autoimmune disorders. We
believe our innovative CUE Biologics(TM) platform approach to selectively modulate
disease relevant T cells, provides a transformative solution to the challenges
facing prevailing immunotherapeutics. By directly engaging and modulating
disease relevant T cells in the patient’s body via an injectable drug, we
believe our biologic drug candidates will be able to realize the true potential
of immune modulation. Through our proprietary CUE Biologics(TM) platform, we
believe we are uniquely positioned to become a prominent and leading player in
immunotherapy, immuno-oncology, and autoimmune disease.  

Leave a Reply

Your email address will not be published. Required fields are marked *